https://www.selleckchem.com/pr....oducts/ro-61-8048.ht
h with an accuracy of 77%. The non-invasiveness, high productivity, and reasonable cost ensure the availability of this predictive technology in all levels of healthcare.The aim of the study was to develop a technology for anti-thrombogenic drug coating of biodegradable porous scaffolds and to evaluate the physicomechanical and hemocompatible properties of functionally active vascular prostheses with and without a drug coating. Vascular prostheses from polyhydroxybutyrate/valerate and polycaprolactone with the incorporated vascular e
Like
Comment
Share
